Goldman Sachs screened for stocks with at least 25% revenue exposure to the Greater China region.
Category: Uncategorized
JPMorgan says buy this pharmaceutical stock following cost-reduction announcement
The bank upped its rating to overweight from neutral and increased its price target.
Goldman upgrades this beer producer, says shares can rally 30%
The bank raised its rating to buy from neutral.
Top Wall Street analysts suggest these 3 stocks for solid growth potential
TipRanks’ analyst ranking service discusses three stocks, including Meta Platforms and Amazon, that are favored by Wall Street’s top pros
Follow the money: Insiders at these companies are buying during the market stress
Recent volatility spurred by uncertainty around President Trump’s tariffs has led some insiders of certain names to buy shares, according to Bank of America.
Berkshire Hathaway now owns 5% of entire Treasury-bill market as Buffett patiently waits for his elephant
JPMorgan estimated that Berkshire’s T-bill position, $314 billion at the end of March, accounted for 5% of all outstanding short-term government bills.
Activist Elliott reaches key agreement with Charles River. Here are three ways to create value
The firm has three possible paths toward value creation at the drug development company.
These stocks, including Microsoft, just entered overbought territory and may be due for a pullback
A number of stocks could be due for a turnaround after seeing meaningful gains this past week amid a broader market pullback.
Five stocks with major upside following earnings, Morgan Stanley says
Morgan Stanley named a slew of stocks to buy following earnings
Palantir is one stock to own in hopes of its growing to a trillion dollar market cap, investor says
Will McGough, Prime Capital Financial director of investments, said Palantir is a buy even though the stock has rallied 55% this year.